Image Credit: STAT News

STAT+: Pharmalittle: We’re reading about Novo ending Hims deal, FDA transparency, and more

Watchdoq June 23, 2025

Novo Nordisk is halting its collaboration with Hims & Hers Health over the sale of weight loss drugs